The 3 most recent market catalysts affecting $SGP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 5, 2026
Corporate Catalyst
Neutral
Impact 55
HC Wainwright & Co. Reiterates Buy on SpyGlass Pharma, Maintains $37 Price Target
HC Wainwright & Co. analyst Yi Chen has reaffirmed a 'Buy' rating and a $37 price target for SpyGlass Pharma (SGP). This action signals that the analyst's fundamental outlook on th…
Aug 14, 2026
Corporate Catalyst
Neutral
Impact 65
Raymond James Initiates Coverage On SpyGlass Pharma with Outperform Rating, Announces Price Target of $39
Raymond James analyst Christopher Raymond has initiated coverage on SpyGlass Pharma (SGP) with an 'Outperform' rating and a $39 price target. This event is significant as it marks …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.